Movement Disorders

Teva is dedicated to advancing care and treatment options for those living with neurological movement disorders, particularly Huntington’s disease (HD) and tardive dyskinesia (TD).

Tardive dyskinesia (TD) is another serious disorder, typically arising as a side effect of prolonged use of certain medications, particularly antipsychotics. TD is characterized by repetitive, uncontrollable body movements such as grimacing, blinking, and other facial or body movements. These symptoms can be physically exhausting and emotionally distressing, creating significant challenges for those affected. The unpredictable and often irreversible nature of TD adds to the complexity of managing this condition, requiring specialized care and treatment strategies for those living with TD. 

Tardive dyskinesia (TD) is another serious disorder, typically arising as a side effect of prolonged use of certain medications, particularly antipsychotics. TD is characterized by repetitive, uncontrollable body movements such as grimacing, blinking, and other facial or body movements. These symptoms can be physically exhausting and emotionally distressing, creating significant challenges for those affected. The unpredictable and often irreversible nature of TD adds to the complexity of managing this condition, requiring specialized care and treatment strategies for those living with TD. 

Teva is at the forefront of addressing these movement disorders through extensive research, development, and patient-centered initiatives. Our robust portfolio of treatments is designed to improve the quality of life for individuals with Huntington’s disease and TD. We continually invest in research and collaborate with healthcare professionals to refine our approach, ensuring that our therapies are as effective as possible. 

Teva’s dedication to this therapeutic area extends beyond the development of medications. We’re committed to educating the public and healthcare professionals about the impact of movement disorders, advocating for increased awareness and understanding. By doing so, we aim to reduce stigma and improve the lives of those living with these conditions. Through our ongoing efforts in research, patient care, and advocacy, Teva is committed to leading the way in the treatment and support of movement disorders.